Related Experiment Video
Updated: Jun 27, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets
Jiali Zhang1, Jingna Liu, Ling Li
1State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China.
Nutrition Research (New York, N.Y.)
|December 17, 2008
Summary
Chitosan supplementation in rats reduced body weight gain and improved cholesterol levels by increasing fecal fat excretion. This indicates chitosan
Area of Science:
- Nutritional Science
- Biochemistry
Background:
- Hypercholesterolemia is a significant risk factor for cardiovascular diseases.
- Dietary interventions are crucial for managing lipid levels.
- Chitosan, a biopolymer, has shown potential hypolipidemic effects.
Purpose of the Study:
- To investigate the hypolipidemic mechanism of chitosan in a rat model.
- To evaluate the impact of chitosan on lipid metabolism and excretion.
Main Methods:
- Male Sprague-Dawley rats were divided into five groups: normal fat control, high-fat control, positive control (cholestyramine), and two chitosan groups.
- Chitosan was administered either at the beginning or after two weeks of a 6-week feeding study.
- Measurements included body weight gain, food intake, fecal fat and cholesterol excretion, plasma and liver lipid levels, and liver enzyme activities.
Main Results:
- Chitosan significantly decreased body weight gain and increased fecal fat and cholesterol excretion compared to the high-fat control group.
- Plasma and liver lipid levels were reduced, while hepatic and lipoprotein lipase activities were increased by chitosan.
- Chitosan administration showed a tendency to alleviate fatty liver tissue degeneration.
Conclusions:
- Chitosan effectively reduces dietary fat and cholesterol absorption in vivo.
- Chitosan demonstrates potential as a therapeutic agent for improving hypercholesterolemia in rats.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...